Loading clinical trials...
Loading clinical trials...
Allograft of Hematopoietic Stem Cells With Reduced-intensity Conditioning From a HLA-haploidentical Family Donor: Phase II Study of Combined Immunosuppression Before and After Transplantation
Conditions
Interventions
anti-thymocyte globulin
busulfan
+5 more
Locations
1
France
Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes
Marseille, France
Start Date
January 1, 2008
Primary Completion Date
January 1, 2010
Last Updated
January 28, 2010
NCT05529069
NCT06263491
NCT06285890
NCT07388563
NCT06311227
NCT06337318
Lead Sponsor
Institut Paoli-Calmettes
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions